Co-Authors
This is a "connection" page, showing publications co-authored by Chenjian Gu and Xia Cai.
Connection Strength
0.515
-
Protoporphyrin IX and verteporfin potently inhibit SARS-CoV-2 infection in vitro and in a mouse model expressing human ACE2. Sci Bull (Beijing). 2021 May 15; 66(9):925-936.
Score: 0.229
-
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2. Front Immunol. 2021; 12:653189.
Score: 0.058
-
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response. Signal Transduct Target Ther. 2020 11 27; 5(1):282.
Score: 0.057
-
Griffithsin with A Broad-Spectrum Antiviral Activity by Binding Glycans in Viral Glycoprotein Exhibits Strong Synergistic Effect in Combination with A Pan-Coronavirus Fusion Inhibitor Targeting SARS-CoV-2 Spike S2 Subunit. Virol Sin. 2020 12; 35(6):857-860.
Score: 0.057
-
Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines. Proc Natl Acad Sci U S A. 2020 11 03; 117(44):27141-27147.
Score: 0.057
-
Survival of SARS-COV-2 under liquid medium, dry filter paper and acidic conditions. Cell Discov. 2020; 6(1):57.
Score: 0.056